cerrar
Tagged with P

Eddy Wu – Founder & CEO, Arctic Vision, China
Dr Eddy Wu, founder and CEO of new Chinese ophthalmology biotech Arctic Vision outlines the specific unmet ophthalmology needs in the Chinese market,…

Key Challenges for Life Sciences & Healthcare in 2020:…
‘The Key Challenges: Life Sciences and Healthcare 2020’ is the latest report from Cornerstone International Group based on a global survey of…

Johnsee Lee – Chairman & CEO & Eric Yang –…
Johnsee Lee and Eric Yang of Taiwanese precision medicine diagnostics firm Quark Biosciences outline their technology’s unique characteristics, how…

“Medication Adherence” is a Lunatic Endeavour
John G. Singer outlines why a focus on patients' adherence to their medication is not necessarily useful in working to improve health outcomes and why…

Kyung Suk Kim – CEO, Corestem
Kyung Suk Kim, CEO of Corestem, the first company to receive approval for a stem cell therapy for Amyotrophic Lateral Sclerosis (ALS) in Korea,…

Latin America Pharma News Roundup June 2020
In recent pharma news from around Latin America, countries are beginning to manufacture their own tests and equipment for dealing with the COVID-19…

China Biotech News Roundup June 15th 2020
A roundup of the latest news from Chinese biotechs, including a bumper IPO for Legend Biotech, a USD two million tie-up between Roche and Innovent…

Pharma Faces: Bae Byoungjun, KoNECT, Korea
With over 30 years of experience in public office working in public health and pharmaceutical policy, food and drug safety regulations, national…

Top 10 Pharma Companies in Japan
Japan's pharma market is one of the world's biggest, with a value of around USD 95 billion, according to figures from the country's Ministry of…

Parallel Trade in Belgium: Rebuffing the Critics
Stakeholders from the Belgian parallel trade industry outline how their activities are helping to solve medicine shortages in Europe and ensure…

Key Challenges for Life Sciences & Healthcare in 2020:…
‘The Key Challenges: Life Sciences and Healthcare 2020’ is the latest report from Cornerstone International Group based on a global survey of…

Peter L. Saltonstall – President & CEO, National…
Peter L Saltonstall, president and CEO of the US National Organization for Rare Disorders (NORD) shares the organization’s key priorities, what…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here